HIA
WST icon

Harbor Investment Advisory’s West Pharmaceutical WST Stock Holding History

Harbor Investment Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$7.7K – 1366
2025
Q4 		$7.7K Hold
28
– – ﹤0.01% 982
2025
Q3 		$7.34K Hold
28
– – ﹤0.01% 950
2025
Q2 		$6.13K Sell
28
-12
-30% -$2.56K ﹤0.01% 973
2025
Q1 		$8.96K Buy
40
+8
+25% +$2.21K ﹤0.01% 892
2024
Q4 		$10.5K Buy
32
+5
+19% +$1.57K ﹤0.01% 865
2024
Q3 		$8.1K Buy
27
+14
+108% +$4.29K ﹤0.01% 911
2024
Q2 		$4.28K Hold
13
– – ﹤0.01% 990
2024
Q1 		$5.14K Hold
13
– – ﹤0.01% 968
2023
Q4 		$4.58K Hold
13
– – ﹤0.01% 956
2023
Q3 		$4.88K Hold
13
– – ﹤0.01% 922
2023
Q2 		$4.97K Hold
13
– – ﹤0.01% 1129
2023
Q1 		$4.5K Hold
13
– – ﹤0.01% 1146
2022
Q4 		$3.06K Buy
+13
New +$3.08K ﹤0.01% 1165

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbor Investment Advisory's WST Position: Q1 2026 in Review

Harbor Investment Advisory sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 28 shares — an estimated $7.7K sold.

Harbor Investment Advisory first reported a position in WST in Q4 2022 and held it in 13 quarters. The position peaked at $10.5K in Q4 2024. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Harbor Investment Advisory reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Harbor Investment Advisory sold 28 West Pharmaceutical shares in Q1 2026, an estimated $7.7K.
  • Harbor Investment Advisory first reported a position in West Pharmaceutical in Q4 2022 and held it in 13 quarters.
  • Harbor Investment Advisory's West Pharmaceutical position peaked at $10.5K in Q4 2024.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Harbor Investment Advisory's 13F filing for Q1 2026, filed 23 Apr 2026.